Literature DB >> 34187409

Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort study.

Chansik An1,2, Jong Won Choi3, Hyung Soon Lee4, Hyunsun Lim2, Seok Jong Ryu1, Jung Hyun Chang5,6, Hyun Cheol Oh2,7.   

Abstract

BACKGROUND: Almost all Koreans are covered by mandatory national health insurance and are required to undergo health screening at least once every 2 years. We aimed to develop a machine learning model to predict the risk of developing hepatocellular carcinoma (HCC) based on the screening results and insurance claim data.
METHODS: The National Health Insurance Service-National Health Screening database was used for this study (NHIS-2020-2-146). Our study cohort consisted of 417,346 health screening examinees between 2004 and 2007 without cancer history, which was split into training and test cohorts by the examination date, before or after 2005. Robust predictors were selected using Cox proportional hazard regression with 1000 different bootstrapped datasets. Random forest and extreme gradient boosting algorithms were used to develop a prediction model for the 9-year risk of HCC development after screening. After optimizing a prediction model via cross validation in the training cohort, the model was validated in the test cohort.
RESULTS: Of the total examinees, 0.5% (1799/331,694) and 0.4% (390/85,652) in the training cohort and the test cohort were diagnosed with HCC, respectively. Of the selected predictors, older age, male sex, obesity, abnormal liver function tests, the family history of chronic liver disease, and underlying chronic liver disease, chronic hepatitis virus or human immunodeficiency virus infection, and diabetes mellitus were associated with increased risk, whereas higher income, elevated total cholesterol, and underlying dyslipidemia or schizophrenic/delusional disorders were associated with decreased risk of HCC development (p < 0.001). In the test, our model showed good discrimination and calibration. The C-index, AUC, and Brier skill score were 0.857, 0.873, and 0.078, respectively.
CONCLUSIONS: Machine learning-based model could be used to predict the risk of HCC development based on the health screening examination results and claim data.

Entities:  

Keywords:  Big data; Liver neoplasms; Machine learning; Precision medicine

Year:  2021        PMID: 34187409     DOI: 10.1186/s12885-021-08498-w

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  18 in total

1.  Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II.

Authors:  Takehiro Michikawa; Manami Inoue; Norie Sawada; Motoki Iwasaki; Yasuhito Tanaka; Taichi Shimazu; Shizuka Sasazuki; Taiki Yamaji; Masashi Mizokami; Shoichiro Tsugane
Journal:  Prev Med       Date:  2012-06-04       Impact factor: 4.018

2.  Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

Authors:  Hwai-I Yang; Man-Fung Yuen; Henry Lik-Yuen Chan; Kwang-Hyub Han; Pei-Jer Chen; Do-Young Kim; Sang-Hoon Ahn; Chien-Jen Chen; Vincent Wai-Sun Wong; Wai-Kay Seto
Journal:  Lancet Oncol       Date:  2011-04-14       Impact factor: 41.316

3.  Random survival forests for competing risks.

Authors:  Hemant Ishwaran; Thomas A Gerds; Udaya B Kogalur; Richard D Moore; Stephen J Gange; Bryan M Lau
Journal:  Biostatistics       Date:  2014-04-11       Impact factor: 5.899

Review 4.  A review of feature selection methods in medical applications.

Authors:  Beatriz Remeseiro; Veronica Bolon-Canedo
Journal:  Comput Biol Med       Date:  2019-07-31       Impact factor: 4.589

5.  Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.

Authors:  Yao-Chun Hsu; Terry Cheuk-Fung Yip; Hsiu J Ho; Vincent Wai-Sun Wong; Yen-Tsung Huang; Hashem B El-Serag; Teng-Yu Lee; Ming-Shiang Wu; Jaw-Town Lin; Grace Lai-Hung Wong; Chun-Ying Wu
Journal:  J Hepatol       Date:  2018-03-16       Impact factor: 25.083

6.  High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B.

Authors:  Vincent Wai-Sun Wong; Jun Yu; Alfred Sze-Lok Cheng; Grace Lai-Hung Wong; Hoi-Yun Chan; Eagle Siu-Hong Chu; Enders Kai-On Ng; Francis Ka-Leung Chan; Joseph Jao-Yao Sung; Henry Lik-Yuen Chan
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

Review 7.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

8.  Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

Authors:  Cristina Ripoll; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman Grace; Andrew Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; Robert Makuch; David Patch; Daniel S Matloff
Journal:  J Hepatol       Date:  2009-03-05       Impact factor: 25.083

9.  Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea.

Authors:  Sang Cheol Seong; Yeon-Yong Kim; Sue K Park; Young Ho Khang; Hyeon Chang Kim; Jong Heon Park; Hee-Jin Kang; Cheol-Ho Do; Jong-Sun Song; Eun-Joo Lee; Seongjun Ha; Soon Ae Shin; Seung-Lyeal Jeong
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

10.  Introducing big data analysis using data from National Health Insurance Service.

Authors:  EunJin Ahn
Journal:  Korean J Anesthesiol       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.